{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:43:02Z","timestamp":1783186982829,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.msard.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T01:51:41Z","timestamp":1520473901000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort"],"prefix":"10.1016","volume":"21","author":[{"given":"K.","family":"Soelberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jarius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wildemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.T.","family":"Lillevang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.msard.2018.03.003_bib1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. experience of the optic neuritis treatment trial","volume":"109","author":"Optic Neuritis Study Group","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.msard.2018.03.003_bib2","article-title":"Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: a predominantly population-based study","author":"Asgari","year":"2017","journal-title":"Mult. Scler."},{"issue":"18","key":"10.1016\/j.msard.2018.03.003_bib3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2018.03.003_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1352458511417480","article-title":"HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica","volume":"18","author":"Asgari","year":"2012","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2018.03.003_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/112067210501500319","article-title":"Paraneoplastic optic neuropathy in a patient with a non-small cell lung carcinoma: a case report","volume":"15","author":"Asproudis","year":"2005","journal-title":"Eur. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.msard.2018.03.003_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/367781","article-title":"HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course","volume":"72","author":"Barcellos","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.msard.2018.03.003_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jns.2016.09.002","article-title":"Prevalence of anti-SOX1 reactivity in various neurological disorders","volume":"369","author":"Berger","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.msard.2018.03.003_bib8","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1371\/journal.pone.0000664","article-title":"HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis","volume":"2","author":"Brynedal","year":"2007","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.msard.2018.03.003_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.humimm.2015.09.015","article-title":"Advances in DNA sequencing technologies for high resolution HLA typing","volume":"76","author":"Cereb","year":"2015","journal-title":"Hum. Immunol."},{"issue":"9313","key":"10.1016\/j.msard.2018.03.003_bib10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.msard.2018.03.003_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2018.03.003_bib12","doi-asserted-by":"crossref","first-page":"e1000024","DOI":"10.1371\/journal.pgen.1000024","article-title":"Defining the role of the MHC in autoimmunity: a review and pooled analysis","volume":"4","author":"Fernando","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.msard.2018.03.003_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways","volume":"224","author":"Fife","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.msard.2018.03.003_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.msard.2018.03.003_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archneur.1997.00550130058016","article-title":"HLA typing in acute optic neuritis. Relation to multiple sclerosis and magnetic resonance imaging findings","volume":"54","author":"Frederiksen","year":"1997","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2018.03.003_bib16","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/0961203311403344","article-title":"Optic neuropathy as a presenting feature of systemic lupus erythematosus: two case reports and literature review","volume":"20","author":"Frigui","year":"2011","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.msard.2018.03.003_bib17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2018.03.003_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","article-title":"Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen","volume":"291","author":"Jarius","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2018.03.003_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2018.03.003_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.msard.2018.03.003_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-0420.2007.01034.x","article-title":"Unilateral optic neuritis as the presenting symptom of human immunodeficiency virus toxoplasmosis infection","volume":"86","author":"Kallenbach","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.msard.2018.03.003_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-9-29","article-title":"DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP)","volume":"9","author":"Kaushansky","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.msard.2018.03.003_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00401-012-1015-3","article-title":"Targeting intracerebral inflammation in multiple sclerosis: is it feasible?","volume":"124","author":"Lassmann","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2018.03.003_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.msard.2018.03.003_bib25","doi-asserted-by":"crossref","first-page":"e58352","DOI":"10.1371\/journal.pone.0058352","article-title":"Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles","volume":"8","author":"Mero","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.msard.2018.03.003_bib26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients","volume":"13","author":"Pache","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2018.03.003_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2018.03.003_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.20022119","article-title":"Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis","volume":"198","author":"Salama","year":"2003","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.msard.2018.03.003_bib29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.50.3.708","article-title":"Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings","volume":"50","author":"Soderstrom","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.03.003_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/1352458517734070","article-title":"A population-based prospective study of optic neuritis","author":"Soelberg","year":"2017","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2018.03.003_bib31","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1212\/NXI.0000000000000252","article-title":"Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer","volume":"3","author":"Soelberg","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2018.03.003_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.msard.2018.03.003_bib33","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.4049\/jimmunol.0901038","article-title":"Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease","volume":"183","author":"Trabattoni","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.msard.2018.03.003_bib34","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/bjo.2006.109371","article-title":"The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis","volume":"91","author":"Tuwir","year":"2007","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.msard.2018.03.003_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2018.03.003_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/gene.2012.46","article-title":"Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue","volume":"13","author":"Zheng","year":"2012","journal-title":"Genes Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818300890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818300890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:41:15Z","timestamp":1761900075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818300890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"alternative-id":["S2211034818300890"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.03.003","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}